Good morning, everyone, and welcome to our Q2 2025 conference call. Our CFO, Peter Delly, and I, Gavin O'Dowd, will take you through our results starting at slide four.
I would like to focus on three key aspects of our operational highlights, beginning first with our nicotine pouch Q2 volume, which showed a year-on-year growth of 23% on a like-for-like basis. We would like to highlight that this doesn't reflect two key impacts on comparability, which reduced our growth rates: one, the Easter effect, which moved from Q1 in 2024 to Q2 in 2025, which we highlighted in our Q1 presentation. We estimate that this impacted growth by approximately three percentage points. And two, in Q2 2024, it was an exceptional quarter driven by shortages in the US.
Much of the incremental traffic we received due to these shortages resulted in sales of non-US Zyn brands, which grew over 50% quarter on quarter in Q2 24.
Please refer to our Q2 24 presentation for more context.
Adjusting for these factors, nicotine pouch growth rates are similar in Q2 to Q1 2025.
Secondly, revenue continued to grow at approximately 20% on a like-for-like basis, adjusting for Easter. In line with the last 12 months performance.
And lastly, I would like to draw your attention to the material increase in our gross margin.
Our business philosophy is built around sharing our economies of scale with our consumers in the form of superior convenience and best value.
And despite aggressively moving forward on both of these areas, Haypp was still able to increase its gross margin by nearly five percentage points to 19%, reflecting the power of our operating model. Moving to slide five.
I'd like to touch on how the US market is changing and how we are investing. Starting with the market on the left-hand side, the overall market continues to show robust growth, driven both by customers moving into the category and by increased consumption rates for those who have been in the category for a number of years. The US Nicotine pouch category is now larger than the US legal category.
In parallel, fragmentation within the category continues to accelerate with further introductions of FDA-approved products. As an anecdote, we launched more Nicotine pouch SKUs in the US in Q2 2025 than in all of 2024.
Regulation remains stable, with early signs of an increasing emphasis on ensuring that existing rules are complied with rather than introducing new legislation.
While this is more evident in the vape category, it bodes well for nicotine pouches as well. In conclusion, we believe the overall conditions for compliant online retail are extremely bright, and we will continue to allocate resources accordingly.
Moving to the right-hand side of the slide, which focuses more on our US investment priorities, which we touched upon in our Capital Markets Day in April.
Since then, we have reinforced the team capabilities, with our CTO recently relocating to our US office. In addition, we have recruited a Head of Customer Acquisition, and in keeping with our commitment to compliance, we have onboarded both Heads of Legal and Regulatory Affairs. We consider these additions to our team to be an excellent bedrock to build a sustainable business from.
We will focus much of our effort in recent months towards further improving our retention rates, which is key to maximizing the returns we will achieve from new customers in the future.
Initiatives such as the same-day delivery in Houston, which has now been expanded to a broader area, and the new loyalty program, are key drivers to this improvement.
While we continue to further sharpen our retention rates, we will also trial a range of tools to accelerate our customer acquisition rates and assess their success before allocating material resources. And finally, as we said in our Q1 release, we see US Zyn supply and demand aligning within the US market, and we continue to expect a return to selling Zyn at some stage in the second half of 2025. Moving to slide six, which covers legal and regulatory updates. We remain engaged in two legal cases in Stockholm.
The appeal process is ongoing, in line with expectations. We expect this will take between 1 and 6 months.
And as previously stated, we don't expect any material impact from the outcome of this case. In San Francisco, settlement discussions are ongoing. The EU released an initial draft of a tax proposal on nicotine products, including nicotine pouches. As with previous EU tobacco tax initiatives, we expect the final outcome to be radically different from the initial proposal, especially given the number of member states that have openly opposed this draft. However, we do welcome that nicotine pouches are clearly recognized as a category in the draft, which is a strong step towards recognizing the category in other areas of regulation.
In the UK, a nationwide ban on disposable nicotine vaping devices came into effect on June 1st, 2025.
Vape manufacturers are changing to similarly branded rechargeable plug systems to limit consumer confusion. We believe the shift benefits online retailers over the long term through high prices and full compliance with new regulation. However, the transition by offline retailers from disposables continues, creating a temporary distortion within the market. With that, I will now hand over to Peter for an update on our financial performance.
Thank you. Good morning everyone. We have concluded a successful quarter for underlying sales.